SCHEMBL7708152

SCHEMBL7708152

C/C=C/CN1CCCCC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CARM1 Q86X55 1/20 0.37
PRMT6 Q96LA8 1/20 0.37
PRMT8 Q9NR22 1/20 0.37
LTA4H P09960 1/20 0.36
HRH3 Q9Y5N1 4/20 0.36
CHRNB2 P17787 1/20 0.35
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
CHRNA4 P43681 1/20 0.35
ALDH1A1 P00352 1/20 0.34
POLB P06746 1/20 0.34
MAPT P10636 1/20 0.34
SIGMAR1 Q99720 2/20 0.34
HTR2A P28223 1/20 0.34
HTR2C P28335 1/20 0.34
HTR2B P41595 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7708069 1.00 CARM1 (0.37) CARM1PRMT6PRMT8LTA4HHRH3
SCHEMBL8907193 1.00 CARM1 (0.37) CARM1PRMT6PRMT8LTA4HHRH3
SCHEMBL3302686 1.00 CARM1 (0.37) CARM1PRMT6PRMT8LTA4HHRH3
SCHEMBL15901483 1.00 CARM1 (0.37) CARM1PRMT6PRMT8LTA4HHRH3
SCHEMBL27476039 1.00 CARM1 (0.37) CARM1PRMT6PRMT8LTA4HHRH3
SCHEMBL15901482 1.00 CARM1 (0.37) CARM1PRMT6PRMT8LTA4HHRH3
Hydrochloric Acid SCHEMBL29036868 0.97 CARM1 (0.36) CARM1PRMT6PRMT8LTA4HHRH3
SCHEMBL5943069 0.97
SCHEMBL7704845 0.97
SCHEMBL1819311 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11248064-B2 Conjugated diene polymer, conjugated diene polymer composition, and tire JAPAN ELASTOMER CO., LTD. (JP) 2022-02-15 US disclosed
EP-3268000-B1 PYRAZOLO[1,5-A][1,3,5]TRIAZINE AND PYRAZOLO[1,5-A]PYRIMIDINE DERIVATIVES AS CDK INHIBITORS AURIGENE DISCOVERY TECH LTD (IN) 2021-08-04 EP disclosed
EP-3581597-B1 CONJUGATED DIENE POLYMER, CONJUGATED DIENE POLYMER COMPOSITION, AND TIRE JAPAN ELASTOMER CO LTD (JP) 2021-05-05 EP disclosed
EP-3517552-B1 MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER COMPOSITION, TIRE, AND METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER JAPAN ELASTOMER CO LTD (JP) 2020-11-11 EP disclosed
US-10822446-B2 Modified conjugated diene polymer, modified conjugated diene polymer composition, tire, and method for producing modified conjugated diene polymer JAPAN ELASTOMER CO., LTD. (JP) 2020-11-03 US disclosed
US-10766972-B2 Modified conjugated diene-based polymer and method for producing the same, and modified conjugated diene-based polymer composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2020-09-08 US disclosed
EP-3517552-A1 MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER COMPOSITION, TIRE, AND METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER Japan Elastomer Co., Ltd. (JP) 2019-07-31 EP disclosed
EP-3260476-B1 MODIFIED CONJUGATED DIENE-BASED POLYMER, MANUFACTURING METHOD THEREOF, AND MODIFIED CONJUGATED DIENE-BASED POLYMER COMPOSITION ASAHI CHEMICAL IND (JP) 2019-05-08 EP disclosed
EP-3120852-B1 PREVENTIVE AND/OR THERAPEUTIC AGENT FOR IMMUNE DISEASES TAIHO PHARMACEUTICAL CO LTD (JP) 2019-05-01 EP disclosed
US-20180037674-A1 Modified Conjugated Diene-Based Polymer and Method for Producing the Same, and Modified Conjugated Diene-Based Polymer Composition ASAHI KASEI KABUSHIKI KAISHA (JP) 2018-02-08 US disclosed
US-9085653-B2 Method for producing modified conjugated diene-based polymer, modified conjugated diene-based polymer, modified conjugated diene-based polymer composition, rubber composition and tire ASAHI KASEI CHEMICALS CORPORATION (JP) 2015-07-21 US disclosed
EP-2754674-B1 METHOD FOR PRODUCING MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER, MODIFIED CONJUGATED DIENE POLYMER COMPOSITION, RUBBER COMPOSITION, AND TIRE ASAHI KASEI CHEMICALS CORP (JP) 2015-03-11 EP disclosed
WO-2015022926-A1 NOVEL FUSED PYRIMIDINE COMPOUND OR SALT THEREOF 大鵬薬品工業株式会社 (JP) 2015-02-19 WO disclosed
US-20140213721-A1 Method for Producing Modified Conjugated Diene-Based Polymer, Modified Conjugated Diene-Based Polymer, Modified Conjugated Diene-Based Polymer Composition, Rubber Composition and Tire ASAHI KASEI CHEMICALS CORPORATION (JP) 2014-07-31 US disclosed
CN-103764683-A Method for producing modified conjugated diene polymer, modified conjugated diene polymer, modified conjugated diene polymer composition, rubber composition, and tire ASAHI KASEI CHEMICALS CORP 2014-04-30 CN disclosed
US-20130274256-A1 NOVEL INHIBITORS OF BACTERIAL BIOFILMS AND RELATED METHODS SEQUOIA SCIENCES, INC. (US) 2013-10-17 US disclosed
US-7365196-B2 Sulphonamido-substituted bridged bicycloalkyl derivatives MERCK SHARP & DOHME LTD. (GB) 2008-04-29 US disclosed
US-7365196-B2 Sulphonamido-substituted bridged bicycloalkyl derivatives MERCK SHARP & DOHME LTD. (GB) 2008-04-29 US disclosed
US-6359174-B1 REACTING ALLYL REACTANT WITH ACID CHLORIDE IN PRESENCE OF LEWIS ACID CATALYST THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2002-03-19 US disclosed
CN-1331694-A Antihistaminic spiro compounds JANSSEN PHARMACEUTICA NV (BE) 2002-01-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130274256-A1 NOVEL INHIBITORS OF BACTERIAL BIOFILMS AND RELATED METHODS BLVRB, MMP8, PGLS CARM1 4423/4885PRMT6 3233/4885PRMT8 3363/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.